Correlation Between CSL and Cara Therapeutics
Can any of the company-specific risk be diversified away by investing in both CSL and Cara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Cara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL Limited and Cara Therapeutics, you can compare the effects of market volatilities on CSL and Cara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Cara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Cara Therapeutics.
Diversification Opportunities for CSL and Cara Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CSL and Cara is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding CSL Limited and Cara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cara Therapeutics and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL Limited are associated (or correlated) with Cara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cara Therapeutics has no effect on the direction of CSL i.e., CSL and Cara Therapeutics go up and down completely randomly.
Pair Corralation between CSL and Cara Therapeutics
Assuming the 90 days horizon CSL Limited is expected to under-perform the Cara Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, CSL Limited is 6.46 times less risky than Cara Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Cara Therapeutics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 228.00 in Cara Therapeutics on December 19, 2024 and sell it today you would earn a total of 256.00 from holding Cara Therapeutics or generate 112.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 81.36% |
Values | Daily Returns |
CSL Limited vs. Cara Therapeutics
Performance |
Timeline |
CSL Limited |
Cara Therapeutics |
Risk-Adjusted Performance
Solid
Weak | Strong |
CSL and Cara Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CSL and Cara Therapeutics
The main advantage of trading using opposite CSL and Cara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Cara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutics will offset losses from the drop in Cara Therapeutics' long position.CSL vs. Spirent Communications plc | CSL vs. T Mobile | CSL vs. Entravision Communications | CSL vs. China Communications Services |
Cara Therapeutics vs. Novo Nordisk AS | Cara Therapeutics vs. CSL LTD SPONADR | Cara Therapeutics vs. CSL Limited | Cara Therapeutics vs. Mercedes Benz Group AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
CEOs Directory Screen CEOs from public companies around the world |